Short Interest in International Stem Cell Co. (OTCMKTS:ISCO) Expands By 400.0%

International Stem Cell Co. (OTCMKTS:ISCO) saw a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 1,500 shares, a growth of 400.0% from the December 15th total of 300 shares. Based on an average daily trading volume, of 22,400 shares, the short-interest ratio is currently 0.1 days.

International Stem Cell Stock Performance

ISCO traded down $0.02 on Monday, reaching $0.10. The company had a trading volume of 10,055 shares, compared to its average volume of 4,939. International Stem Cell has a 52-week low of $0.05 and a 52-week high of $0.20. The company has a market cap of $800,000.00, a price-to-earnings ratio of -1.25 and a beta of 0.21. The business has a 50 day simple moving average of $0.09 and a 200 day simple moving average of $0.08.

About International Stem Cell

International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.